Skip to main content
20 minutes minimum delay
Aptinyx Inc. Logo Aptinyx Inc. Logo
  • Our Approach
    • Our Approach
    • NDMA Receptors
    • Therapeutic Area Focus
  • Pipeline
  • Clinical Studies
  • Investors
  • About Us
    • About Aptinyx
    • Leadership Team
    • Board of Directors
    • Working at Aptinyx
    • Contact Us

Site Search

Press Releases

  • Investor Relations
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Analyst Coverage
    • Financials & Filings
      • Quarterly Results
      • Annual Reports & Proxy
      • SEC Filings
    • Governance
      • Governance Documents & Charters
      • Executive Management
      • Board of Directors
      • Committee Composition
    • FAQ & Contacts
      • Investor Contacts
      • Investor FAQs
      • Investor Email Alerts
      • RSS Feeds
Normal
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015
November 14, 2016
Aptinyx to Present Data for NYX-2925 in Models of Neuropathic Pain and Traumatic Brain Injury at Neuroscience 2016
Download PDF format download (opens in new window)
November 10, 2016
Aptinyx Awarded Up to $2.85 Million in NIH Grants to Research NMDA Receptor Modulation for the Treatment of Neuropathic Pain and Age-Related Cognitive Decline
Download PDF format download (opens in new window)
September 13, 2016
Aptinyx Receives FDA Fast Track Designation for Development of NYX-2925 as Treatment for Neuropathic Pain Associated with Diabetic Peripheral Neuropathy
Download PDF format download (opens in new window)
July 13, 2016
Aptinyx Initiates Dosing in Phase 1 Clinical Study of Lead NMDA-Receptor Modulator, NYX-2925
Download PDF format download (opens in new window)
May 10, 2016
Aptinyx Raises $65 Million in Series A Financing to Advance Therapies for Neurological Disorders
Download PDF format download (opens in new window)

Quick Links

  • Press Releases
  • Events & Presentations
  • Stock Information

IR Contact

ir@aptinyx.com
847-871-0377

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Aptinyx Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Aptinyx Inc. to send you the requested Investor Email Alert updates.

* Required

*
*





Unsubscribe

Email Alert Sign Up Confirmation

© Aptinyx Inc.   |   Terms of Use   |   Privacy Policy   |  
909 Davis Street, Suite 600, Evanston, IL 60201
Powered By Q4 Inc. 5.86.0.1 (opens in new window)